Senior scientist Zhou Han sets up a quantitative PCR (polymerase chain reaction) to check the effect of a drug in cell assays at Stoke Therapeutics, a company that is looking for a genetic cure for epilepsy, in Bedford, MA on May 2, 2018.
Pat Greenhouse | Boston Globe | Getty Images
(This story is for CNBC Pro subscribers only.)
Investors at the Sohn Healthcare Investment Conference recommended a handful of public stocks that are on the cutting edge of health innovation.
The healthcare-focused conference took place Wednesday to provide investment insight as well as raise money to help fight Covid-19. CNBC Pro broke down the recommendations from the panel’s speakers.